HEADER HYDROLASE 10-DEC-07 3BL7 TITLE SYNTHETIC GENE ENCODED DCPS BOUND TO INHIBITOR DG156844 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SCAVENGER MRNA-DECAPPING ENZYME DCPS; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 38-337; COMPND 5 SYNONYM: DCS-1, HINT- RELATED 7MEGMP-DIRECTED HYDROLASE, HISTIDINE COMPND 6 TRIAD PROTEIN MEMBER 5, HINT-5; COMPND 7 EC: 3.-.-.-; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DCPS, DCS1, HINT5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PBAD KEYWDS MRNA DECAPPING ENZYME, DCPS, LIGAND COMPLEX, CYTOPLASM, HYDROLASE, KEYWDS 2 NONSENSE-MEDIATED MRNA DECAY, NUCLEUS, POLYMORPHISM, STRUCTURAL KEYWDS 3 GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, ACCELERATED KEYWDS 4 TECHNOLOGIES CENTER FOR GENE TO 3D STRUCTURE, ATCG3D EXPDTA X-RAY DIFFRACTION AUTHOR B.L.STAKER,J.CHRISTENSEN,L.STEWART,ACCELERATED TECHNOLOGIES CENTER AUTHOR 2 FOR GENE TO 3D STRUCTURE (ATCG3D) REVDAT 7 30-AUG-23 3BL7 1 REMARK SEQADV REVDAT 6 06-OCT-09 3BL7 1 TITLE REVDAT 5 08-SEP-09 3BL7 1 AUTHOR REVDAT 4 09-JUN-09 3BL7 1 REVDAT REVDAT 3 24-FEB-09 3BL7 1 VERSN REVDAT 2 16-DEC-08 3BL7 1 JRNL REVDAT 1 21-OCT-08 3BL7 0 JRNL AUTH J.SINGH,M.SALCIUS,S.W.LIU,B.L.STAKER,R.MISHRA,J.THURMOND, JRNL AUTH 2 G.MICHAUD,D.R.MATTOON,J.PRINTEN,J.CHRISTENSEN,J.M.BJORNSSON, JRNL AUTH 3 B.A.POLLOK,M.KILEDJIAN,L.STEWART,J.JARECKI,M.E.GURNEY JRNL TITL DCPS AS A THERAPEUTIC TARGET FOR SPINAL MUSCULAR ATROPHY. JRNL REF ACS CHEM.BIOL. V. 3 711 2008 JRNL REFN ISSN 1554-8929 JRNL PMID 18839960 JRNL DOI 10.1021/CB800120T REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.95 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 3 NUMBER OF REFLECTIONS : 22214 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.214 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1184 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1577 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.67 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.3260 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4759 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 211 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.50000 REMARK 3 B22 (A**2) : -0.14000 REMARK 3 B33 (A**2) : -0.64000 REMARK 3 B12 (A**2) : -0.06000 REMARK 3 B13 (A**2) : 0.21000 REMARK 3 B23 (A**2) : -0.29000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.752 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.312 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.232 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.457 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.921 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.860 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4902 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3388 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6653 ; 1.210 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8216 ; 0.877 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 571 ; 6.167 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 258 ;34.606 ;23.566 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 854 ;16.436 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 43 ;19.170 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 733 ; 0.067 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5383 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1016 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 933 ; 0.195 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3584 ; 0.194 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2232 ; 0.171 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2679 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 237 ; 0.198 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.178 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 75 ; 0.211 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 12 ; 0.176 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3770 ; 0.594 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1138 ; 0.068 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4677 ; 0.675 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2323 ; 0.983 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1976 ; 1.524 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3BL7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-DEC-07. REMARK 100 THE DEPOSITION ID IS D_1000045657. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23402 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.310 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.12300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.31 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.39 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.43000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1ST0 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.05 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350, AMMONIUM FORMATE, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8840 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 37 REMARK 465 ALA A 38 REMARK 465 PRO A 39 REMARK 465 VAL A 40 REMARK 465 ARG A 41 REMARK 465 ALA A 71 REMARK 465 SER A 72 REMARK 465 GLY A 73 REMARK 465 ASP A 74 REMARK 465 GLY A 75 REMARK 465 ASP A 76 REMARK 465 GLY A 77 REMARK 465 GLN A 335 REMARK 465 GLN A 336 REMARK 465 SER A 337 REMARK 465 SER B 37 REMARK 465 ALA B 38 REMARK 465 PRO B 39 REMARK 465 GLU B 70 REMARK 465 ALA B 71 REMARK 465 SER B 72 REMARK 465 GLY B 73 REMARK 465 ASP B 74 REMARK 465 GLY B 75 REMARK 465 ASP B 76 REMARK 465 GLY B 77 REMARK 465 SER B 337 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 339 O HOH B 355 2.00 REMARK 500 O HOH B 339 O HOH B 444 2.04 REMARK 500 OD1 ASP A 198 O HOH A 939 2.18 REMARK 500 ND1 HIS A 262 O HOH A 919 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 51 127.58 -170.82 REMARK 500 SER A 101 75.73 -110.12 REMARK 500 ASP A 111 -112.77 60.08 REMARK 500 ILE A 161 -57.21 -120.13 REMARK 500 TYR A 274 62.81 -100.50 REMARK 500 LEU A 276 134.65 -31.99 REMARK 500 ARG A 294 -32.76 -137.80 REMARK 500 PHE B 47 105.96 -50.85 REMARK 500 LYS B 51 140.59 -171.68 REMARK 500 ASP B 111 -131.02 64.51 REMARK 500 TYR B 274 58.38 -92.05 REMARK 500 ASP B 308 77.44 -157.31 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DD1 A 901 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1ST0 RELATED DB: PDB REMARK 900 STRUCTURE OF DCPS BOUND TO M7GPPPG REMARK 900 RELATED ID: 1ST4 RELATED DB: PDB REMARK 900 STRUCTURE OF DCPS BOUND TO M7GPPPA REMARK 900 RELATED ID: 3BL9 RELATED DB: PDB REMARK 900 DCPS BOUND TO INHIBITOR DG157493 REMARK 900 RELATED ID: 3BLA RELATED DB: PDB REMARK 900 DCPS BOUND TO INHIBITOR DG153249 DBREF 3BL7 A 38 337 UNP Q96C86 DCPS_HUMAN 38 337 DBREF 3BL7 B 38 337 UNP Q96C86 DCPS_HUMAN 38 337 SEQADV 3BL7 SER A 37 UNP Q96C86 EXPRESSION TAG SEQADV 3BL7 SER B 37 UNP Q96C86 EXPRESSION TAG SEQRES 1 A 301 SER ALA PRO VAL ARG LEU PRO PHE SER GLY PHE ARG LEU SEQRES 2 A 301 GLN LYS VAL LEU ARG GLU SER ALA ARG ASP LYS ILE ILE SEQRES 3 A 301 PHE LEU HIS GLY LYS VAL ASN GLU ALA SER GLY ASP GLY SEQRES 4 A 301 ASP GLY GLU ASP ALA VAL VAL ILE LEU GLU LYS THR PRO SEQRES 5 A 301 PHE GLN VAL GLU GLN VAL ALA GLN LEU LEU THR GLY SER SEQRES 6 A 301 PRO GLU LEU GLN LEU GLN PHE SER ASN ASP ILE TYR SER SEQRES 7 A 301 THR TYR HIS LEU PHE PRO PRO ARG GLN LEU ASN ASP VAL SEQRES 8 A 301 LYS THR THR VAL VAL TYR PRO ALA THR GLU LYS HIS LEU SEQRES 9 A 301 GLN LYS TYR LEU ARG GLN ASP LEU ARG LEU ILE ARG GLU SEQRES 10 A 301 THR GLY ASP ASP TYR ARG ASN ILE THR LEU PRO HIS LEU SEQRES 11 A 301 GLU SER GLN SER LEU SER ILE GLN TRP VAL TYR ASN ILE SEQRES 12 A 301 LEU ASP LYS LYS ALA GLU ALA ASP ARG ILE VAL PHE GLU SEQRES 13 A 301 ASN PRO ASP PRO SER ASP GLY PHE VAL LEU ILE PRO ASP SEQRES 14 A 301 LEU LYS TRP ASN GLN GLN GLN LEU ASP ASP LEU TYR LEU SEQRES 15 A 301 ILE ALA ILE CYS HIS ARG ARG GLY ILE ARG SER LEU ARG SEQRES 16 A 301 ASP LEU THR PRO GLU HIS LEU PRO LEU LEU ARG ASN ILE SEQRES 17 A 301 LEU HIS GLN GLY GLN GLU ALA ILE LEU GLN ARG TYR ARG SEQRES 18 A 301 MET LYS GLY ASP HIS LEU ARG VAL TYR LEU HIS TYR LEU SEQRES 19 A 301 PRO SER TYR TYR HIS LEU HIS VAL HIS PHE THR ALA LEU SEQRES 20 A 301 GLY PHE GLU ALA PRO GLY SER GLY VAL GLU ARG ALA HIS SEQRES 21 A 301 LEU LEU ALA GLU VAL ILE GLU ASN LEU GLU CYS ASP PRO SEQRES 22 A 301 ARG HIS TYR GLN GLN ARG THR LEU THR PHE ALA LEU ARG SEQRES 23 A 301 ALA ASP ASP PRO LEU LEU LYS LEU LEU GLN GLU ALA GLN SEQRES 24 A 301 GLN SER SEQRES 1 B 301 SER ALA PRO VAL ARG LEU PRO PHE SER GLY PHE ARG LEU SEQRES 2 B 301 GLN LYS VAL LEU ARG GLU SER ALA ARG ASP LYS ILE ILE SEQRES 3 B 301 PHE LEU HIS GLY LYS VAL ASN GLU ALA SER GLY ASP GLY SEQRES 4 B 301 ASP GLY GLU ASP ALA VAL VAL ILE LEU GLU LYS THR PRO SEQRES 5 B 301 PHE GLN VAL GLU GLN VAL ALA GLN LEU LEU THR GLY SER SEQRES 6 B 301 PRO GLU LEU GLN LEU GLN PHE SER ASN ASP ILE TYR SER SEQRES 7 B 301 THR TYR HIS LEU PHE PRO PRO ARG GLN LEU ASN ASP VAL SEQRES 8 B 301 LYS THR THR VAL VAL TYR PRO ALA THR GLU LYS HIS LEU SEQRES 9 B 301 GLN LYS TYR LEU ARG GLN ASP LEU ARG LEU ILE ARG GLU SEQRES 10 B 301 THR GLY ASP ASP TYR ARG ASN ILE THR LEU PRO HIS LEU SEQRES 11 B 301 GLU SER GLN SER LEU SER ILE GLN TRP VAL TYR ASN ILE SEQRES 12 B 301 LEU ASP LYS LYS ALA GLU ALA ASP ARG ILE VAL PHE GLU SEQRES 13 B 301 ASN PRO ASP PRO SER ASP GLY PHE VAL LEU ILE PRO ASP SEQRES 14 B 301 LEU LYS TRP ASN GLN GLN GLN LEU ASP ASP LEU TYR LEU SEQRES 15 B 301 ILE ALA ILE CYS HIS ARG ARG GLY ILE ARG SER LEU ARG SEQRES 16 B 301 ASP LEU THR PRO GLU HIS LEU PRO LEU LEU ARG ASN ILE SEQRES 17 B 301 LEU HIS GLN GLY GLN GLU ALA ILE LEU GLN ARG TYR ARG SEQRES 18 B 301 MET LYS GLY ASP HIS LEU ARG VAL TYR LEU HIS TYR LEU SEQRES 19 B 301 PRO SER TYR TYR HIS LEU HIS VAL HIS PHE THR ALA LEU SEQRES 20 B 301 GLY PHE GLU ALA PRO GLY SER GLY VAL GLU ARG ALA HIS SEQRES 21 B 301 LEU LEU ALA GLU VAL ILE GLU ASN LEU GLU CYS ASP PRO SEQRES 22 B 301 ARG HIS TYR GLN GLN ARG THR LEU THR PHE ALA LEU ARG SEQRES 23 B 301 ALA ASP ASP PRO LEU LEU LYS LEU LEU GLN GLU ALA GLN SEQRES 24 B 301 GLN SER HET DD1 A 901 28 HETNAM DD1 5-{[1-(2-FLUOROBENZYL)PIPERIDIN-4- HETNAM 2 DD1 YL]METHOXY}QUINAZOLINE-2,4-DIAMINE FORMUL 3 DD1 C21 H24 F N5 O FORMUL 4 HOH *211(H2 O) HELIX 1 1 GLN A 90 THR A 99 1 10 HELIX 2 2 PRO A 121 ASN A 125 5 5 HELIX 3 3 THR A 136 TYR A 143 1 8 HELIX 4 4 THR A 154 ILE A 161 1 8 HELIX 5 5 ILE A 161 SER A 168 1 8 HELIX 6 6 ILE A 173 ASP A 181 1 9 HELIX 7 7 GLU A 185 ILE A 189 5 5 HELIX 8 8 GLN A 212 ASP A 215 5 4 HELIX 9 9 SER A 229 LEU A 233 5 5 HELIX 10 10 THR A 234 GLU A 236 5 3 HELIX 11 11 HIS A 237 ARG A 257 1 21 HELIX 12 12 LYS A 259 ASP A 261 5 3 HELIX 13 13 LEU A 298 ASP A 308 1 11 HELIX 14 14 ARG A 310 ARG A 315 1 6 HELIX 15 15 ASP A 325 GLU A 333 1 9 HELIX 16 16 GLN B 90 GLY B 100 1 11 HELIX 17 17 PRO B 121 ASN B 125 5 5 HELIX 18 18 THR B 136 LEU B 144 1 9 HELIX 19 19 THR B 154 ILE B 161 1 8 HELIX 20 20 ILE B 161 SER B 168 1 8 HELIX 21 21 ILE B 173 ASP B 181 1 9 HELIX 22 22 SER B 229 LEU B 233 5 5 HELIX 23 23 THR B 234 GLU B 236 5 3 HELIX 24 24 HIS B 237 ARG B 257 1 21 HELIX 25 25 LYS B 259 ASP B 261 5 3 HELIX 26 26 LEU B 298 ASP B 308 1 11 HELIX 27 27 ARG B 310 ARG B 315 1 6 HELIX 28 28 ASP B 325 ALA B 334 1 10 SHEET 1 A 6 ARG A 48 SER A 56 0 SHEET 2 A 6 ILE A 61 LYS A 67 -1 O LYS A 67 N ARG A 48 SHEET 3 A 6 ASP A 79 LYS A 86 -1 O VAL A 82 N LEU A 64 SHEET 4 A 6 VAL A 127 VAL A 132 -1 O THR A 130 N ILE A 83 SHEET 5 A 6 TYR B 113 LEU B 118 -1 O SER B 114 N VAL A 131 SHEET 6 A 6 LEU B 104 ASN B 110 -1 N GLN B 107 O THR B 115 SHEET 1 B 6 GLU A 103 ASN A 110 0 SHEET 2 B 6 TYR A 113 PHE A 119 -1 O THR A 115 N GLN A 107 SHEET 3 B 6 VAL B 127 VAL B 132 -1 O VAL B 131 N SER A 114 SHEET 4 B 6 ASP B 79 LYS B 86 -1 N ILE B 83 O THR B 130 SHEET 5 B 6 ILE B 61 LYS B 67 -1 N LEU B 64 O VAL B 82 SHEET 6 B 6 ARG B 48 SER B 56 -1 N ARG B 54 O PHE B 63 SHEET 1 C 2 LEU A 148 GLU A 153 0 SHEET 2 C 2 LEU A 317 ARG A 322 -1 O LEU A 321 N ARG A 149 SHEET 1 D 6 PHE A 191 ASN A 193 0 SHEET 2 D 6 PHE A 200 PRO A 204 -1 O LEU A 202 N PHE A 191 SHEET 3 D 6 TYR A 217 CYS A 222 -1 O ILE A 219 N ILE A 203 SHEET 4 D 6 HIS A 277 ALA A 282 -1 O PHE A 280 N LEU A 218 SHEET 5 D 6 LEU A 263 HIS A 268 -1 N TYR A 266 O HIS A 279 SHEET 6 D 6 ALA A 295 LEU A 297 -1 O HIS A 296 N LEU A 267 SHEET 1 E 2 LEU B 148 GLU B 153 0 SHEET 2 E 2 LEU B 317 ARG B 322 -1 O LEU B 321 N ARG B 149 SHEET 1 F 6 PHE B 191 ASN B 193 0 SHEET 2 F 6 PHE B 200 PRO B 204 -1 O LEU B 202 N PHE B 191 SHEET 3 F 6 TYR B 217 CYS B 222 -1 O ILE B 219 N ILE B 203 SHEET 4 F 6 HIS B 277 ALA B 282 -1 O PHE B 280 N LEU B 218 SHEET 5 F 6 LEU B 263 HIS B 268 -1 N TYR B 266 O HIS B 279 SHEET 6 F 6 ALA B 295 LEU B 297 -1 O HIS B 296 N LEU B 267 CISPEP 1 TYR A 133 PRO A 134 0 -6.14 CISPEP 2 TYR A 269 LEU A 270 0 1.67 CISPEP 3 TYR B 133 PRO B 134 0 -9.25 CISPEP 4 TYR B 269 LEU B 270 0 -0.75 SITE 1 AC1 10 LYS A 142 TYR A 143 TRP A 175 GLU A 185 SITE 2 AC1 10 PRO A 204 ASP A 205 LEU A 206 ILE A 219 SITE 3 AC1 10 SER A 272 TYR B 113 CRYST1 49.257 56.271 60.334 118.81 92.39 99.99 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020302 0.003576 0.003025 0.00000 SCALE2 0.000000 0.018045 0.010338 0.00000 SCALE3 0.000000 0.000000 0.019118 0.00000